Hamps Bio IPO Closed
Already have an account? Apply now
Schedule of Hamps Bio
| Issue open date | 13 Dec 2024 |
| Issue close date | 17 Dec 2024 |
| UPI mandate deadline | 17 Dec 2024 (5 PM) |
| Allotment finalization | 18 Dec 2024 |
| Refund initiation | 19 Dec 2024 |
| Share credit | 19 Dec 2024 |
| Listing date | 20 Dec 2024 |
| Mandate end date | 01 Jan 2025 |
| Lock-in end date for anchor investors (50%) | 17 Jan 2025 |
| Lock-in end date for anchor investors (remaining) | 18 Mar 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Hamps Bio
Hamps is a pharmaceutical and food processing company that markets and distributes pharmaceutical formulations and manufactures freeze-dried and frozen products. The company has a strong presence in India and is expanding globally. While its pharmaceutical business is well-established, its FDFP business, though growing, contributes a smaller portion to overall revenue. Hamps’s strong brand, experienced management, and focus on quality position it for future growth.
Financials of Hamps Bio
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹6.22 crores |
| Fresh Issue | ₹6.22 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Purchase of Plant and Machinery | 3.59 (57.72%) |
| Enhancing brand awareness | 0.50 (8.04%) |
| General corporate purposes | 1.52 (24.42%) |
Strengths
- Established a presence in the FMCG industry with a diversified product portfolio.
- Strong distribution network ensuring broad market reach and visibility.
- Consistent investment in brand awareness and visibility campaigns.
- Focus on enhancing operational efficiencies and profitability.
Risks
- High reliance on external funding for operational and expansion activities.
- Vulnerability to regulatory changes and compliance requirements.
- Competitive pressures from both domestic and international players in the FMCG sector.
- Potential risks arising from economic slowdowns affecting consumer spending.